Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors

OBJECTIVE: Examine the effect of tamoxifen and aromatase inhibitors (AIs) on the risk of 12 clinically relevant cardiovascular outcomes in postmenopausal female breast cancer survivors. METHODS: We carried out two prospective cohort studies among postmenopausal women with breast cancer in UK primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, Anthony A, Peacock Hinton, Sharon, Stanway, Susannah, Lyon, Alexander Richard, Smeeth, Liam, Lund, Jennifer L, Bhaskaran, Krishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiac Risk Factors and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327412/
https://www.ncbi.nlm.nih.gov/pubmed/33177117
http://dx.doi.org/10.1136/heartjnl-2020-317510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327412/
https://www.ncbi.nlm.nih.gov/pubmed/33177117
http://dx.doi.org/10.1136/heartjnl-2020-317510

Ejemplares similares